Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Simulations Plus, Inc. (SLP : NSDQ)
 
 • Company Description   
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.

Number of Employees: 247

 
 • Price / Volume Information   
Yesterday's Closing Price: $17.75 Daily Weekly Monthly
20 Day Moving Average: 558,357 shares
Shares Outstanding: 20.11 (millions)
Market Capitalization: $356.97 (millions)
Beta: 0.83
52 Week High: $44.33
52 Week Low: $16.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -36.13% -39.59%
12 Week -31.04% -42.15%
Year To Date -36.36% -40.39%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
800 PARK OFFICES DRIVE SUITE 401
-
RESEARCH TRIANGLE PARK,NC 27709
USA		 ph: 661-723-7723
fax: 661-723-5524		 slp@finprofiles.com http://www.simulations-plus.com
 
 • General Corporate Information   
Officers
Shawn O'Connor - Chief Executive Officer
Walter S. Woltosz - Chairman of the Board of Directors
Will Frederick - Chief Financial Officer & Chief Operating Officer
Lisa LaVange - Director
Daniel Weiner - Director

Peer Information
Simulations Plus, Inc. (ATEA)
Simulations Plus, Inc. (BITS.)
Simulations Plus, Inc. (DCTM)
Simulations Plus, Inc. (DLVAZ)
Simulations Plus, Inc. (DOCC)
Simulations Plus, Inc. (NEON)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: COMP-SOFTWARE
Sector: Computer and Technology
CUSIP: 829214105
SIC: 7373
Fiscal Year
Fiscal Year End: August
Last Reported Quarter: 02/01/25
Next Expected EPS Date: 07/14/25
Share - Related Items
Shares Outstanding: 20.11
Most Recent Split Date: 10.00 (2.00:1)
Beta: 0.83
Market Capitalization: $356.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.27 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.00 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: -0.36
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 17.66
Trailing 12 Months: 24.32
PEG Ratio: -
Price Ratios
Price/Book: 1.88
Price/Cash Flow: 23.14
Price / Sales: 4.54
EPS Growth
vs. Year Ago Period: 55.00%
vs. Previous Quarter: 82.35%
Sales Growth
vs. Year Ago Period: 22.55%
vs. Previous Quarter: 18.54%
ROE
05/31/25 - -
02/28/25 - 7.86
11/30/24 - 6.84
ROA
05/31/25 - -
02/28/25 - 7.35
11/30/24 - 6.34
Current Ratio
05/31/25 - -
02/28/25 - 4.37
11/30/24 - 4.15
Quick Ratio
05/31/25 - -
02/28/25 - 4.37
11/30/24 - 4.15
Operating Margin
05/31/25 - -
02/28/25 - 18.55
11/30/24 - 16.67
Net Margin
05/31/25 - -
02/28/25 - 9.18
11/30/24 - 10.97
Pre-Tax Margin
05/31/25 - -
02/28/25 - -
11/30/24 - -
Book Value
05/31/25 - -
02/28/25 - 9.43
11/30/24 - 9.19
Inventory Turnover
05/31/25 - -
02/28/25 - -
11/30/24 - -
Debt-to-Equity
05/31/25 - -
02/28/25 - 0.00
11/30/24 - 0.00
Debt-to-Capital
05/31/25 - -
02/28/25 - 0.00
11/30/24 - 0.00
 

Powered by Zacks Investment Research ©